Finding Health Online
News for:   
 

   
 

For this drug, our server compiled this detailed Chemical Profile.

You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.

 

 
 
 
 

 

Click the Chemical Profile link above for detailed information.

Visit Betterchem's Drug Index for…

  • Exclusivity
    Patents and market exclusivity

  • Drug Information
    Prescribing and other information

  • DMFs
    Type 2 drug master files

  • Databases
    Free access to database search

  • 21 CFR
    FDA regulations for this drug

  • Federal Register
    FR search results for this drug

  • Drug Recalls
    For Rx's using this API

  FDA Approval Activities for this Drug…

Fenofibrate Capsules (Micronized), 67 mg, Novopharm Limited ANDA 75-753 9/3/02 Fenofibrate Capsules (Micronized), 134 & 200 mg, (67 mg, strength remains ) Novopharm Limited ANDA 75-753 4/9/02 4/10/03 Fenofibrate Capsules (Micronized), 67, 134, & 200 mg, Impax, ANDA 75-868 Tricor Micro/Fenfibrate Capsules, 67 mg, Fournier Research/Abbott NDA 019-304/S-001 2/9/98 10/26/98 Tricor Indication: As an adjunctive therapy to diet for the treatment of adult patients with very high elevations of serum triglyceride levels who are at risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. Tricor (fenofibrate) Capsules-Micronized, Abbott NDA 19-304/S-005 4/24/00 4/27/00 6/8/01 Tricor Indication: Treatment of Hypercholesterolemia as adjunctive therapy to diet for the reduction of low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides, and apolipoprotein B (Apo B) in adult patients withe primary hypercholesterolemia or mixed dyslipidemia (Frederickson Types IIa and IIb). Tricor (Fenofibrate) Tablets, 54 & 160 mg, Abbott NDA 21-203 Fenofibrate Capsules (Micronized), Impax, FENOFIBRATE Capsule; 134MG FENOFIBRATE (MICRONIZED) Teva 075753 FENOFIBRATE Capsule; 200MG FENOFIBRATE (MICRONIZED) Teva 075753 FENOFIBRATE Capsule; 67MG FENOFIBRATE (MICRONIZED) Teva 021203 FENOFIBRATE Tablet; 160MG TRICOR Abbott 021203 FENOFIBRATE Tablet; 54MG TRICOR Abbott Fenofibrate Tablets, Teva Pharmaceuticals, Fenofibrate Tablets, Impax Pharmaceuticals, Fenofibrate Tablets, Ranbaxy Laboratories | Tricor (fenofibrate) Tablets, Abbott, Approval | Antara (Fenofibrate) Capsules, Reliant Pharma, Approval | Fenofibrate Tablets, Par Pharmaceutical, Tentative Approval | Fenofibrate Tablets, Teva Pharma, 2nd Tentative Approval | Triglide (fenofibrate) Tablets, Skye Pharma, Approval | Fenofibrate Tablets, Teva Pharma, Approval | Fenofibrate Tablets, Ranbaxy Labs, Approval | Lipofen (fenofibrate capsules), Cipher Pharma, Approval | Triglide (fenofibrate) Tablets, First Horizon Pharma, Labeling Revision

Visit Betterchem's Drug Index for FDA's latest approval information.


 

Find other drugs…

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News

© 2011 FindingHealthOnline